Stocks and Investing
Stocks and Investing
Mon, June 3, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Samantha Semenkow Initiated (SNSE) at Strong Buy and Held Target at $4 on, Jun 3rd, 2024
Samantha Semenkow of Citigroup, Initiated "Sensei Biotherapeutics, Inc." (SNSE) at Strong Buy and Held Target at $4 on, Jun 3rd, 2024.
Samantha has made no other calls on SNSE in the last 4 months.
There are 2 other peers that have a rating on SNSE. Out of the 2 peers that are also analyzing SNSE, 0 agree with Samantha's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Samantha
- Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $4 on, Friday, May 24th, 2024
- Sudan Loganathan of "Stephens & Co." Reiterated at Buy and Held Target at $5 on, Friday, May 24th, 2024
Contributing Sources